Takuma Narita
Papers
4
Total Citations
52
H-Index
4
About
Dr. Takuma Narita is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly in elderly and frail patient populations. His major contributions center on evaluating the safety and efficacy of robot-assisted radical prostatectomy (RARP) in men aged 75 years and older, demonstrating that advanced age alone should not preclude surgical intervention. Notably, his work on frailty—the FRARP-QL Study—provides critical longitudinal data on how preoperative frailty impacts postoperative quality of life and lower urinary tract symptoms, guiding personalized treatment decisions. Dr. Narita has also pioneered the use of total cell-free DNA (cfDNA) as a novel biomarker for quantifying surgical tissue damage, offering a more objective method for assessing perioperative trauma in urological surgeries. With over 50 citations across his most-cited papers, his research bridges oncologic outcomes with patient-reported experiences, advancing the field of geriatric urologic oncology. His investigations into neoadjuvant chemohormonal therapy combined with minimally invasive surgery for high-risk prostate cancer further underscore his commitment to improving both survival and recovery for complex patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4